Literature DB >> 16336277

A FYVE-containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi.

Stefan Kunz1, Michael Oberholzer, Thomas Seebeck.   

Abstract

Cyclic-nucleotide-specific phosphodiesterases (PDEs) are key players in the intracellular signaling pathways of the important human pathogen Trypanosoma cruzi. We report herein the identification of an unusual PDE from this protozoal organism. This enzyme, TcrPDEC, is a member of the class I PDEs, as determined from the presence of a characteristic signature sequence and from the conservation of a number of functionally important amino acid residues within its catalytic domain. Class I PDEs include a large number of PDEs from eukaryotes, among them all 11 human PDE families. Unusually for an enzyme of this class, TcrPDEC contains a FYVE-type domain in its N-terminal region, followed by two closely spaced coiled-coil domains. Its catalytic domain is located in the middle of the polypeptide chain, whereas all other class I enzymes contain their catalytic domains in their C-terminal parts. TcrPDEC can complement a PDE-deficient yeast strain. Unexpectedly for a kinetoplastid PDE, TcrPDEC is a dual-specificity PDE that accepts both cAMP and cGMP as its substrates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16336277     DOI: 10.1111/j.1742-4658.2005.05039.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  17 in total

1.  The role of acidocalcisomes in the stress response of Trypanosoma cruzi.

Authors:  Roberto Docampo; Veronica Jimenez; Sharon King-Keller; Zhu-hong Li; Silvia N J Moreno
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

2.  Chemical validation of phosphodiesterase C as a chemotherapeutic target in Trypanosoma cruzi, the etiological agent of Chagas' disease.

Authors:  Sharon King-Keller; Minyong Li; Alyssa Smith; Shilong Zheng; Gurpreet Kaur; Xiaochuan Yang; Binghe Wang; Roberto Docampo
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

3.  Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi.

Authors:  Rocío Díaz-Benjumea; Sunil Laxman; Thomas R Hinds; Joseph A Beavo; Ana Rascón
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

4.  Hydrolysis products of cAMP analogs cause transformation of Trypanosoma brucei from slender to stumpy-like forms.

Authors:  Sunil Laxman; Aaron Riechers; Martin Sadilek; Frank Schwede; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

5.  Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.

Authors:  Thomas Seebeck; Geert Jan Sterk; Hengming Ke
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

6.  Defining the role of a FYVE domain in the localization and activity of a cAMP phosphodiesterase implicated in osmoregulation in Trypanosoma cruzi.

Authors:  Alejandra C Schoijet; Kildare Miranda; Lia Carolina Soares Medeiros; Wanderley de Souza; Mirtha M Flawiá; Héctor N Torres; Omar P Pignataro; Roberto Docampo; Guillermo D Alonso
Journal:  Mol Microbiol       Date:  2010-10-28       Impact factor: 3.501

Review 7.  A contractile vacuole complex is involved in osmoregulation in Trypanosoma cruzi.

Authors:  Peter Rohloff; Roberto Docampo
Journal:  Exp Parasitol       Date:  2007-05-10       Impact factor: 2.011

8.  Discovery of novel Trypanosoma brucei phosphodiesterase B1 inhibitors by virtual screening against the unliganded TbrPDEB1 crystal structure.

Authors:  Chimed Jansen; Huanchen Wang; Albert J Kooistra; Chris de Graaf; Kristina M Orrling; Hermann Tenor; Thomas Seebeck; David Bailey; Iwan J P de Esch; Hengming Ke; Rob Leurs
Journal:  J Med Chem       Date:  2013-03-01       Impact factor: 7.446

9.  A high-resolution solution structure of a trypanosomatid FYVE domain.

Authors:  Haydyn D T Mertens; Judy M Callaghan; James D Swarbrick; Malcolm J McConville; Paul R Gooley
Journal:  Protein Sci       Date:  2007-09-28       Impact factor: 6.725

10.  Quantitative proteomic and phosphoproteomic analysis of Trypanosoma cruzi amastigogenesis.

Authors:  Rayner M L Queiroz; Sébastien Charneau; Samuel C Mandacaru; Veit Schwämmle; Beatriz D Lima; Peter Roepstorff; Carlos A O Ricart
Journal:  Mol Cell Proteomics       Date:  2014-09-15       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.